Treating Drug-Resistant Childhood Schizophrenia

Key facts

Sponsor

Northwell Health

Principal Investigator

Christoph U. Correll, MD

The Zucker Hillside Hospital

Intervention

Olanzapine(drug)

Enrollment

41 enrolled

Eligibility

10-18 years · All sexes

Timeline

2001 – 2006

Study locations (3)

• Sagamore Children's Psychiatric Center, Dix Hills, New York, United States
• Long Island Jewish Medical Center, Glen Oaks, New York, United States
• Bronx Children's Psychiatric Center, The Bronx, New York, United States

Collaborators

National Institute of Mental Health (NIMH)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Childhood-onset schizophrenia

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT05340348
  Patientheque in Patients With a Psychosis .
  University Hospital, Brest
• ACTIVE NOT RECRUITINGNCT00001246
  Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers
  National Institute of Mental Health (NIMH)

See all trials for Childhood-onset schizophrenia →